The tumor-activated IL-12 prodrug WTX-330 expanded/activated tumor infiltrating lymphocytes and caused tumor regression in patients with refractory solid tumors: interim data from an ongoing Ph1 study
Publication Title
SITC Annual Meeting; November 13; Houston, TX. 2024;12(Suppl 2): 672
Document Type
Abstract
Publication Date
11-1-2024
Keywords
oregon; chiles
Area of Special Interest
Cancer
Specialty/Research Institute
Oncology
Comments
Mahalingam D, Opyrchal M, Moser JC, Rivera IR, Bilen MA, Fountzilas C, Curti BD, Morris K, Nirschl CJ, Ironside S, Park S, Bruno M, Windt P, Subramanian KK, Chopra SS, Isaacs RE, Luke JJ